JP2007326799A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007326799A5 JP2007326799A5 JP2006158442A JP2006158442A JP2007326799A5 JP 2007326799 A5 JP2007326799 A5 JP 2007326799A5 JP 2006158442 A JP2006158442 A JP 2006158442A JP 2006158442 A JP2006158442 A JP 2006158442A JP 2007326799 A5 JP2007326799 A5 JP 2007326799A5
- Authority
- JP
- Japan
- Prior art keywords
- active oxygen
- oxygen scavenging
- galangin
- phloretin
- scavenging enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 claims 6
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 claims 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 239000001301 oxygen Substances 0.000 claims 5
- 102000004190 Enzymes Human genes 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 4
- 230000002000 scavenging effect Effects 0.000 claims 4
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 claims 3
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 claims 3
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 claims 3
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006158442A JP2007326799A (ja) | 2006-06-07 | 2006-06-07 | 活性酸素消去酵素発現促進剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006158442A JP2007326799A (ja) | 2006-06-07 | 2006-06-07 | 活性酸素消去酵素発現促進剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007326799A JP2007326799A (ja) | 2007-12-20 |
| JP2007326799A5 true JP2007326799A5 (enExample) | 2009-03-05 |
Family
ID=38927525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006158442A Pending JP2007326799A (ja) | 2006-06-07 | 2006-06-07 | 活性酸素消去酵素発現促進剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2007326799A (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010005077A1 (ja) * | 2008-07-11 | 2010-01-14 | 財団法人ヒューマンサイエンス振興財団 | パーキンソン病の疾患関連たんぱく質およびその使用 |
| WO2019238376A1 (en) * | 2018-06-14 | 2019-12-19 | Unilever Plc | Foodstuff comprising a preservative |
| JP7166965B2 (ja) * | 2019-03-13 | 2022-11-08 | 株式会社ファンケル | ｂＦＧＦ発現増強用組成物 |
| JP7432218B2 (ja) | 2019-09-11 | 2024-02-16 | 株式会社再春館製薬所 | サクラソウ科植物の抽出物の用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2651132B1 (fr) * | 1989-08-30 | 1993-01-08 | Pacific Chem Co Ltd | Agents de protection des cellules contre les especes chimiques a oxygene actif et leur preparation. |
| FR2655268B1 (fr) * | 1989-12-06 | 1994-10-14 | Secma | Utilisation d'extraits d'algues pour la preparation de compositions pharmaceutiques, cosmetiques, alimentaires ou a usage agricole. |
| FR2822466B1 (fr) * | 2001-03-23 | 2004-07-02 | Diana Ingredients | Fraction phenolique riche en phloridzine et son utilisation en tant qu'agent cosmetique, alimentaire ou nutraceutique |
| JP2004161664A (ja) * | 2002-11-13 | 2004-06-10 | Fancl Corp | プロポリス組成物 |
| JP5596251B2 (ja) * | 2005-10-14 | 2014-09-24 | 丸善製薬株式会社 | 皮膚化粧料及び頭髪化粧料 |
| JP4954531B2 (ja) * | 2005-10-31 | 2012-06-20 | 一丸ファルコス株式会社 | ペルオキシソーム増殖剤応答性受容体活性化剤 |
-
2006
- 2006-06-07 JP JP2006158442A patent/JP2007326799A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008149802A1 (ja) | アンドログラホリドを有効成分とする抗疲労剤及び経口組成物 | |
| FI3457135T3 (fi) | Fabryn taudin hoitovaihtoehtoja | |
| JP2009084295A5 (enExample) | ||
| JP2009084294A5 (enExample) | ||
| BRPI0520082A2 (pt) | formas de dosagem de risedronato | |
| WO2007061661A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| TW200736213A (en) | Dicarboxylic acid derivatives and their use | |
| TNSN08277A1 (en) | Materials and methods for treating chronic fibrotic disease | |
| WO2007087241A3 (en) | Treatment of ischemic disease using thrombopoietin | |
| JP2006219454A5 (enExample) | ||
| TNSN08279A1 (en) | Bayer healthcare ag | |
| BRPI0414347A (pt) | associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade | |
| EP2161023A3 (en) | Anti-angiogenic agents and methods of use. | |
| WO2010123956A3 (en) | 2,5-disubstituted arylsulfonamide ccr3 antagonists | |
| JP2007326799A5 (enExample) | ||
| EA201070084A1 (ru) | Новое применение известных фармакологически активных химических соединений | |
| GB2443793B (en) | Product, method of manufacture and use | |
| JP2023010880A5 (ja) | 疲労感、意欲低下または眠気の改善剤 | |
| ITRM20050514A1 (it) | Olio ozonizzato, principio attivo di elevata stabilita' a base di perossidi utilizzabile per applicazioni terapeutiche mediche e per trattamenti domiciliari similari a quelli dell'ozonoterapia, senza l'utilizzo di ozono gassoso. | |
| JP2013032308A5 (enExample) | ||
| JP2014505679A5 (enExample) | ||
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| GT200600263A (es) | Regimen de dosificacion para prasugrel | |
| UA108980C2 (en) | APPLICATION OF DONEDARONE FOR THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATIONS |